News
The findings indicate that the Cel System supplement range may effectively lower biological age and enhance health metrics, ...
The first clinical trial to test whether adults with peanut allergies can be desensitized has shown great success—with ...
The development of gepotidacin was funded by the pharmaceutical company GSK, which is responsible for manufacturing the new ...
A $38.8 million verdict for participants in a 401(k) plan administered by Pentegra Services Inc. is a step forward for ERISA ...
In a landmark clinical trial people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual care.
The first clinical trial to test whether adults allergic to peanuts can be desensitised has shown great success with two ...
Axial spondyloarthritis trials show increased diversity over time, with more Asian and Hispanic/Latino participants, but ...
The FDA has approved Dupixent for the treatment of patients aged 12 years and older with CSU who remain symptomatic despite H1 antihistamine treatment.
1. Compared to receiving intravenous (directly into a vein (IV)) anti-cancer therapy in hospital outpatient clinics, we are uncertain whether receiving the same therapy at home affects the management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results